StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the medical research company’s stock.
OpGen Trading Down 7.0 %
Shares of NASDAQ OPGN opened at $1.07 on Tuesday. OpGen has a twelve month low of $0.53 and a twelve month high of $9.90. The business has a 50 day simple moving average of $1.12 and a 200-day simple moving average of $1.75.
About OpGen
Read More
- Five stocks we like better than OpGen
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Stock Market Upgrades: What Are They?
- What Does the Future Hold for Eli Lilly?
- Ride Out The Recession With These Dividend Kings
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.